← Eichor
Condition: Intrahepatic Cholangiocarcinoma Icc Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Intrahepatic Cholangiocarcinoma Icc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Phase 2 · 44 location(s) · Beijing InnoCare Pharma Tech Co., Ltd. · NCT05678270Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced
Phase 2 · 1 location(s) · West China Hospital · NCT06859684Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NA · 2 location(s) · Nantes University Hospital · NCT06735560Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study
Phase 3 · 1 location(s) · Shanghai Junshi Bioscience Co., Ltd. · NCT05342194Scout Dose of Resin Microspheres
NA · 1 location(s) · Seoul National University Hospital · NCT07476651A Trial of Apatinib and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable ICC
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06925516Liver Transplantation for Unresectable Intrahepatic Colangiocarcinoma After Sustained Response to Neoadjuvant Treatments
Phase N/A · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06862934Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unr
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06852287Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Chol
Phase 2 · 1 location(s) · Fudan University · NCT07070700A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cis
Phase 1/Phase 2 · 1 location(s) · Shanghai 6th People's Hospital · NCT07632235Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-posi
Phase 3 · 185 location(s) · Jazz Pharmaceuticals · NCT06282575D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC
Phase N/A · 1 location(s) · Fujian Provincial Hospital · NCT06643208PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Color
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05286814Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
Phase N/A · 1 location(s) · Tata Memorial Centre · NCT07337850HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma
Phase 2/Phase 3 · 1 location(s) · Hutchmed · NCT04353375An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT07101237A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients
EARLY_Phase 1 · 1 location(s) · Shanghai Changzheng Hospital · NCT06583993Additional Chemotherapy Administered Directly Into the Liver Using a Chemo Pump in Patients With Bile Duct Cancer Inside
Phase 2 · 1 location(s) · Erasmus Medical Center · NCT06888063A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcin
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07063888GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence
Phase 2 · 2 location(s) · Zhejiang Cancer Hospital · NCT05557578GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
Phase N/A · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06505486Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahep
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT06721286Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT07640048A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
Phase N/A · 1 location(s) · Yingbin Liu, MD, PhD, FACS · NCT07176962
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.